BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17941908)

  • 1. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease.
    Seo JA; Kim NH; Park SY; Kim HY; Ryu OH; Lee KW; Lee J; Kim DL; Choi KM; Baik SH; Choi DS; Kim SG
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):555-60. PubMed ID: 17941908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
    Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study.
    Yan H; Chang X; Xia M; Bian H; Zhang L; Lin H; Chen G; Zeng M; Gao X
    Lipids Health Dis; 2013 Oct; 12():157. PubMed ID: 24160775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study.
    Chang X; Yan H; Bian H; Xia M; Zhang L; Gao J; Gao X
    Lipids Health Dis; 2015 Apr; 14():28. PubMed ID: 25890223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease.
    Kim SG; Kim HY; Seo JA; Lee KW; Oh JH; Kim NH; Choi KM; Baik SH; Choi DS
    Eur J Endocrinol; 2005 Feb; 152(2):225-31. PubMed ID: 15745930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
    Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
    PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.
    Marchesini G; Avagnina S; Barantani EG; Ciccarone AM; Corica F; Dall'Aglio E; Dalle Grave R; Morpurgo PS; Tomasi F; Vitacolonna E
    J Endocrinol Invest; 2005 Apr; 28(4):333-9. PubMed ID: 15966506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
    Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
    Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
    Ciba I; Widhalm K
    Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease.
    Franzini M; Fornaciari I; Fierabracci V; Elawadi HA; Bolognesi V; Maltinti S; Ricchiuti A; De Bortoli N; Marchi S; Pompella A; Passino C; Emdin M; Paolicchi A
    Liver Int; 2012 Apr; 32(4):629-34. PubMed ID: 22098947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.
    Wang X; Chen X; Zhang H; Pang J; Lin J; Xu X; Yang L; Ma J; Ling W; Chen Y
    Diabetes Metab; 2020 Apr; 46(2):119-128. PubMed ID: 31078721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
    Oh HJ; Kim TH; Sohn YW; Kim YS; Oh YR; Cho EY; Shim SY; Shin SR; Han AL; Yoon SJ; Kim HC
    Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.